Australia markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5000-0.0300 (-1.96%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
54,782
55,885
51,988
36,493
23,933
Selling general and administrative
22,139
24,247
25,052
21,800
11,009
Total operating expenses
76,921
80,132
77,040
58,293
34,942
Operating income or loss
-76,921
-80,132
-77,040
-58,293
-34,942
Total other income/expenses net
-35
3
87
21
-143
Income before tax
-65,054
-68,958
-73,326
-57,823
-34,434
Income tax expense
-16,175
2
-9
23
6
Income from continuing operations
-48,879
-68,960
-73,317
-57,846
-34,440
Net income
-48,879
-68,960
-73,317
-57,846
-34,440
Net income available to common shareholders
-48,879
-68,960
-73,317
-57,846
-34,440
Basic EPS
-1.56
-1.44
-1.61
-1.28
-2.40
Diluted EPS
-1.56
-1.44
-1.61
-1.28
-2.40
Basic average shares
46,595
48,015
45,595
45,138
14,364
Diluted average shares
46,595
48,015
45,595
45,138
14,364